Ian M Graham
Ottawa Hospital Research Institute · 412 works · 66,514 citations · h-index 77
Top works
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- Prevention of coronary heart disease in clinical practice
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- Object oriented analysis
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
- The Diagnostic Performance of Computer Programs for the Interpretation of Electrocardiograms
- European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
- Unstable angina: Natural history and determinants of prognosis
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
- Low Circulating Folate and Vitamin B 6 Concentrations
- Factors affecting the 5 year survival rate of men following acute coronary heart disease
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
- Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies* on Coronary Prevention
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel